Cystic Fibrosis Trust
Overview
The Cystic Fibrosis Trust is a United Kingdom-based charity founded in 1964. It is dedicated to funding research to treat and cure cystic fibrosis (CF), improving clinical care, and providing information and support for individuals with the condition and their families. The Trust provides funding, including grants to organizations and research initiatives, to advance the development of new treatments. It also manages the UK CF Registry, a comprehensive database of patient information to support research and care improvement.
Portfolio Companies
4
Website
cysticfibrosis.org.ukInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enterprise Therapeutics | Apr 2017 | Grant | Co-investor |
| OmniSpirant Therapeutics | Feb 2023 | Grant | Co-investor |
| Rostra Therapeutics | Nov 2024 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cystic Fibrosis Trust based?
Cystic Fibrosis Trust is headquartered in United Kingdom.
When was Cystic Fibrosis Trust founded?
Founding year information for Cystic Fibrosis Trust is not publicly available.
How many portfolio companies does Cystic Fibrosis Trust have?
Cystic Fibrosis Trust has 4 portfolio companies in Caplight's dataset.
What are some companies in Cystic Fibrosis Trust's portfolio?
Portfolio companies visible on Caplight include Enterprise Therapeutics, OmniSpirant Therapeutics, Rostra Therapeutics.
What was Cystic Fibrosis Trust's most recent investment shown here?
Cystic Fibrosis Trust's most recent investment in this portfolio sample was in Rostra Therapeutics in 2024.
What sectors does Cystic Fibrosis Trust focus on?
Cystic Fibrosis Trust focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Cystic Fibrosis Trust focus on?
Stage focus information for Cystic Fibrosis Trust is not publicly available.